The clinical implications of HIV infection and aging

scientific article published on April 2016

The clinical implications of HIV infection and aging is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/ODI.12473
P8608Fatcat IDrelease_rbjvxcgeyrg2djiptqwn7j7kje
P698PubMed publication ID27109276

P2093author name stringM John
P2860cites workCystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyQ24635177
HIV-associated lung infections and complications in the era of combination antiretroviral therapyQ27693307
Frailty in older adults: evidence for a phenotypeQ28205094
Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and careQ28251375
Diabetes mellitus and periodontal diseasesQ28286023
The end of AIDS: HIV infection as a chronic diseaseQ28300749
Lessons learned and unlearned in periodontal microbiologyQ28395398
Inflammatory and coagulation biomarkers and mortality in patients with HIV infectionQ28473903
The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) studyQ28541478
CD4+ count-guided interruption of antiretroviral treatmentQ29619489
Higher prevalence of Epstein-Barr virus DNA in deeper periodontal pockets of chronic periodontitis in Japanese patientsQ31132100
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?Q33184007
Systemic effects of inflammation on health during chronic HIV infectionQ33577551
HIV-infected persons continue to lose kidney function despite successful antiretroviral therapyQ33731258
Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasmaQ33792327
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infectionQ33857515
Functional impairment, disability, and frailty in adults aging with HIV-infectionQ34016913
HIV Infection, Inflammation, Immunosenescence, and AgingQ34150710
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?Q34160020
T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral TherapyQ34193786
Inflammation: the link between insulin resistance, obesity and diabetesQ34286695
State of the science: chronic periodontitis and systemic healthQ34304065
Assessment of function and disability in longitudinal studiesQ34353160
The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic reviewQ34418795
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performanceQ34441791
The link between chronic periodontitis and COPD: a common role for the neutrophil?Q34478144
Plasma levels of soluble CD14 independently predict mortality in HIV infectionQ34764002
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatmentQ34937231
Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungiQ35120262
Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patientsQ35465943
Geriatric Syndromes in Older HIV-Infected AdultsQ35652825
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.Q35694353
Dental Infection of Porphyromonas gingivalis Induces Preterm Birth in MiceQ35760449
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working GroupQ36147395
Systemic markers of inflammation in periodontitisQ36309253
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infectionQ36330954
Periodontal disease and systemic conditions: a bidirectional relationship.Q36602669
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infectionQ36718058
Accelerated immune senescence and HIV-1 infectionQ36738887
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysisQ36747893
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summaryQ36812073
Management of human immunodeficiency virus infection in advanced age.Q36933984
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare systemQ36938343
The next therapeutic challenge in HIV: polypharmacyQ37025385
Research into ageing and older peopleQ37082889
Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men.Q37235079
HIV infection and the risk of diabetes mellitus.Q37365031
The level of monocyte turnover predicts disease progression in the macaque model of AIDS.Q37373031
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidityQ37378238
Frailty syndrome: a transitional state in a dynamic processQ37433578
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.Q37439827
The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairmentQ37533136
Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virusQ38008447
Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature reviewQ38122431
Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.Q40273745
Estimating the proportion of patients infected with HIV who will die of comorbid diseasesQ40399268
Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort StudyQ41018780
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort studyQ41757466
Association of subgingival colonization of Candida albicans and other yeasts with severity of chronic periodontitisQ43736848
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort StudyQ43867180
Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infectionQ44725232
Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfectionQ44967738
The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA StudyQ45142138
Development and validation of a prognostic index for 4-year mortality in older adults.Q45975392
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patientsQ46814419
Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremiaQ48023288
Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionQ57181081
Prevention of bacterial pneumonia in HIV infection: focus on smoking cessationQ58812637
P304page(s)79-86
P577publication date2016-04-01
P1433published inOral DiseasesQ15724675
P1476titleThe clinical implications of HIV infection and aging
P478volume22 Suppl 1